The Slc11a1 (Nramp1) gene controls efficacy of mycobacterial treatment of allergic asthma

Journal of Immunology

Volumn 171, Issue 2, 2003, Pages 754-760

  Smit, Joost J ^a,b   Van Loveren, Henk ^b,c   Hoekstra, Maarten O ^d   Karimi, Khalil ^a   Folkerts, Gert ^a   Nijkamp, Frans P ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BRONCHUS HYPERREACTIVITY; CYTOKINE PRODUCTION; GENE CONTROL; LUNG LAVAGE; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM VACCAE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; VACCINATION;

MYCOBACTERIUM VACCAE;

EID: 0037769131     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.2.754     Document Type: Article

References (47)

1. Gerrard, J. W., C. A. Geddes, P. L. Reggin, C. D. Gerrard, and S. Horne. 1976. Serum IgE levels in white and metis communities in Saskatchewan. Ann. Allergy 37:91.
2. Strachan, D. P. 1989. Hay fever, hygiene, and household size. Br. Med. J. 299:1259.
3. Rook, G. A., and J. L. Stanford. 1998. Give us this day our daily germs. Immunol. Today 19:113.
4. Folkerts, G., G. Walzl, and P. J. Openshaw. 2000. Do common childhood infections 'teach' the immune system not to be allergic? Immunol. Today 21:118.
5. Cookson, W. O., and M. F. Moffatt. 1997. Asthma: an epidemic in the absence of infection? Science 275:41.
6. Van den Biggelaar, A. H., R. van Ree, L. C. Rodrigues, B. Lell, A. M. Deelder, P. G. Kremsner, and M. Yazdanbakhsh. 2000. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 356:1723.
7. Rook, G. A., and L. R. Brunet. 2002. Give us this day our daily germs. Biologist 49:145.
8. Yazdanbakhsh, M., P. G. Kremsner, and R. van Ree. 2002. Allergy, parasites, and the hygiene hypothesis. Science 296:490.
9. Rook, G. A. 2000. Clean living increases more than just atopic disease. Immunol. Today 21:249.
10. Erb, K. J., J. W. Holloway, A. Sobeck, H. Moll, and G. Le Gros. 1998. Infection of mice with Mycobacterium bovis-bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J. Exp. Med. 187:561.
11. Herz, U., K. Gerhold, C. Gruber, A. Braun, U. Wahn, H. Renz, and K. Paul. 1998. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J. Allergy Clin. Immunol. 102:867.
12. Hopfenspirger, M. T., and D. K. Agrawal. 2002. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J. Immunol. 168:2516.
13. Zuany-Amorim, C., C. Manlius, A. Trifilieff, L. R. Brunet, G. Rook, G. Bowen, G. Pay, and C. Walker. 2002. Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. J. Immunol. 169:1492.
14. Shirakawa, T., T. Enomoto, S. Shimazu, and J. M. Hopkin. 1997. The inverse association between tuberculin responses and atopic disorder. Science 275:77.
15. Gruber, C., and K. P. Paul. 2002. Tuberculin reactivity and allergy. Allergy 57:277.
16. Jepson, A., A. Fowler, W. Banya, M. Singh, S. Bennett, H. Whittle, and A. V. Hill. 2001. Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa. Infect. Immun. 69:3989.
17. Vidal, S., M. L. Tremblay, G. Govoni, S. Gauthier, G. Sebastiani, D. Malo, E. Skamene, M. Olivier, S. Jothy, and P. Gros. 1995. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182:655.
18. Skamene, E., E. Schurr, and P. Gros. 1998. Infection genomics: Nramp1 as a major determinant of natural resistance to intracellular infections. Annu. Rev. Med. 49:275.
19. Blackwell, J. M. 1996. Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility. Mol. Med. Today 2:205.
20. Alm, J. S., C. B. Sanjeevi, E. N. Miller, P. Dabadghao, G. Lilja, G. Pershagen, J. M. Blackwell, and A. Scheynius. 2002. Atopy in children in relation to BCG vaccination and genetic polymorphisms at SLC11A1 (formerly NRAMP1) and D2S1471. Genes Immun. 3:71.
21. Kampiah, G., N. H. Hunt, N. J. King, and G. Chaudhri. 2000. NADPH oxidase, Nramp1 and nitric oxide synthase 2 in the host antimicrobial response. Rev. Immunogenet. 2:387.
22. Wyllie, S., P. Seu, and J. A. Goss. 2002. The natural resistance-associated macrophage protein 1 Slc11a1 (formerly Nramp1) and iron metabolism in macrophages. Microbes Infect. 4:351.
23. Blackwell, J. M., and S. Searle. 1999. Genetic regulation of macrophage activation: understanding the function of Nramp/(=Ity/Lsh/Bcg). Immunol. Lett. 65:73.
24. Mock, B. A., D. L. Holiday, D. P. Cerretti, S. C. Darnell, A. D. O'Brien, and M. Potter. 1994. Construction of a series of congenic mice with recombinant chromosome 1 regions surrounding the genetic loci for resistance to intracellular parasites (Ity, Lsh, and Bcg), DNA repair responses (Rep-1), and the cytoskeletal protein villin (Vil). Infect. Immun. 62:325.
25. Araujo, L. M., O. G. Ribeiro, M. Siqueira, M. De Franco, N. Starobinas, S. Massa, W. H. Cabrera, D. Mouton, M. Seman, and O. M. Ibanez. 1998. Innate resistance to infection by intracellular bacterial pathogens differs in mice selected for maximal or minimal acute inflammatory response. Eur. J. Immunol. 28:2913.
26. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba. G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156:766.
27. De Bie, J. J., M. Kneepkens, A. D. Kraneveld, E. H. Jonker, P. A. Henricks, F. P. Nijkamp, and A. J. van Oosterhout. 2000. Absence of late airway response despite increased airway responsiveness and eosinophilia in a murine model of asthma. Exp. Lung Res. 26:491.
28. Hessel, E. M., A. J. Van Oosterhout, C. L. Hofstra, J. J. De Bie, J. Garssen, H. Van Loveren, A. K. Verheyen, H. F. Savelkoul, and F. P. Nijkamp. 1995. Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice. Eur. J. Pharmacol. 293:401.
29. Radzioch, D., T. Hudson, M. Boule, L. Barrera, J. W. Urbance, L. Varesio, and E. Skamene. 1991. Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone marrow derived macrophage lines. J. Leukocyte Biol. 50:263.
30. 15N]nitrate in biological fluids. Anal. Biochem. 126:131.
31. Zuany-Amorim, C., E. Sawicka, C. Manlius, A. Le Moine, L. R. Brunet, D. M. Kemeny, G. Bowen, G. Rook, and C. Walker. 2002. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 8:625.
32. Cher, D. J., and T. R. Mosmann. 1987. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones. J. Immunol. 138:3688.
33. Black, C. A. 1999. Delayed type hypersensitivity: current theories with an historic perspective. Dermatol. Online J. 5:7.
34. Soo, S. S., B. Villarreal-Ramos, C. M. Anjam Khan, C. E. Hormaeche, and J. M. Blackwell. 1998. Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nramp1 influences T-helper subset responses and protection against leishmanial challenge. Infect. Immunol. 66:1910.
35. Umetsu, D. T., J. J. McIntire, O. Akbari, C. Macaubas, and R. H. DeKruyff. 2002. Asthma: an epidemic of dysregulated immunity. Nat. Immun. 3:715.
36. Govoni, G., S. Gauthier, F. Billia, N. N. Iscove, and P. Gros. 1997. Cell-specific and inducible Nramp1 gene expression in mouse macrophages in vitro and in vivo. J. Leukocyte Biol. 62:277.
37. Forbes, J. R., and P. Gros. 2001. Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions. Trends Microbiol. 9:397.
38. Van Rooijen, N. 1992. Macrophages as accessory cells in the in vivo humoral immune response: from processing of particulate antigens to regulation by suppression. Semin. Immunol. 4:237.
39. Blackwell, J. M., T. Goswami, C. A. Evans, D. Sibthorpe, N. Papo, J. K. White, S. Searle, E. N. Miller, C. S. Peacock, H. Mohammed, and M. Ibrahim. 2001. SLC11A1 (formerly NRAMP1) and disease resistance. Cell. Microbiol. 3:773.
40. Biggs, T. E., S. T. Baker, M. S. Botham, A. Dhital, C. H. Barton, and V. H. Perry. 2001. Nramp1 modulates iron homoeostasis in vivo and in vitro: evidence for a role in cellular iron release involving de-acidification of intracellular vesicles. Eur. J. Immunol. 31:2060.
41. Mulero, V., S. Searle, J. M. Blackwell, and J. H. Brock. 2002. Solute carrier 11a1 (Slc11a1: formerly Nramp1) regulates metabolism and release of iron acquired by phagocytic, but not transferrin-receptor-mediated, iron uptake. Biochem. J. 363:89.
42. Lafuse, W. P., G. R. Alvarez, and B. S. Zwilling. 2000. Regulation of Nramp1 mRNA stability by oxidants and protein kinase C in RAW264.7 macrophages expressing Nramp1 (Gly169). Biochem. J. 351:687.
43. Zwilling, B. S., D. E. Kuhn, L. Wikoff, D. Brown, and W. Lafuse. 1999. Role of iron in Nramp1-mediated inhibition of mycobacterial growth. Infect. Immun. 67:1386.
44. Weiss, G. 1999. Iron and anemia of chronic disease. Kidney Int. Suppl. 69:S12.
45. Pelletier, M., A. Forget, D. Bourassa, P. Gros, and E. Skamene. 1982. Immunopathology of BCG infection in genetically resistant and susceptible mouse strains. J. Immunol. 129:2179.
46. Gruber, C., L. Nilsson, and B. Bjorksten. 2001. Do early childhood immunizations influence the development of atopy and do they cause allergic reactions? Pediatr. Allergy Immunol. 12:296.
47. Krishna, M. T., and S. S. Salvi. 2002. Could administration of bacille Calmette-Guerin vaccination at birth protect from the development of asthma and allergic diseases in the western world? Has this question been adequately investigated? Pediatr. Allergy Immunol. 13:172.